PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV

On the basis of remarkable antitumor activity, programmed death receptor-1 (PD-1) inhibitors pembrolizumab and nivolumab were approved for the treatment of advanced melanoma in the second-line setting following progression on either CTLA-4 inhibitor ipilimumab or BRAF/MEK inhibitors (for BRAF mutate...

Full description

Saved in:
Bibliographic Details
Main Authors: Diwakar Davar, Melissa Wilson, Chelsea Pruckner, John M. Kirkwood
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2015/737389
Tags: Add Tag
No Tags, Be the first to tag this record!